Glossary

Lithium Monitoring

Lithium monitoring is the regular measurement of blood lithium levels, kidney function, thyroid function, calcium and weight for people taking lithium, most often for Bipolar Disorder. Lithium has a narrow range between an effective and a toxic level, so missed checks can cause serious harm.

Clinically reviewed by Aisha Malik, Clinical Director (GPhC 2205843), on .

What it means in practice

SPS guidance says lithium levels are checked one week after starting, then weekly until stable, then every 3 months for the first year. Once stable, the lithium level, weight or BMI, eGFR, urea and electrolytes, calcium and thyroid function are checked every 3 to 6 months. The sample should be a trough level, taken just before the next dose, 12 hours after the last one. SPS lists people who need lithium levels checked at least every 3 months, including people aged 65 or over, those taking interacting medicines, those at risk of impaired kidney or thyroid function, people with a raised calcium, a significant change in sodium or fluid intake, poor symptom control or poor adherence, those whose last level was 0.8 mmol/L or higher, and people who are pregnant. SPS notes that toxicity can occur from about 1.5 mmol/L. NICE CG185 describes monitoring shared between the specialist team and the GP.

Good practice

  • Keep a register of everyone on lithium with the date and result of their last level
  • Take the level as a trough, 12 hours after the last dose
  • Recall people in the higher-risk groups at least every 3 months
  • Check kidney function, thyroid function and calcium at each routine review
  • Review interacting medicines, including over-the-counter NSAIDs, before they are started

Questions

How often should lithium levels be checked?

According to SPS, weekly after starting until stable, every 3 months for the first year, then every 3 to 6 months once stable. Some groups need checks at least every 3 months.

When should the blood sample be taken?

Just before the next dose, as a trough level 12 hours after the last dose.

Sources

Checked against these sources on 20 November 2026.

  1. Lithium monitoring (SPS)
  2. Bipolar disorder: assessment and management (NICE CG185)

Remote clinical pharmacists, funded through ARRS.

Book a 30-minute call